Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
- PMID: 28000146
- PMCID: PMC5330965
- DOI: 10.1007/s13181-016-0595-z
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
Abstract
Cannabinoid hyperemesis syndrome (CHS) is a syndrome of cyclic vomiting associated with cannabis use. Our objective is to summarize the available evidence on CHS diagnosis, pathophysiology, and treatment. We performed a systematic review using MEDLINE, Ovid MEDLINE, Embase, Web of Science, and the Cochrane Library from January 2000 through September 24, 2015. Articles eligible for inclusion were evaluated using the Grading and Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Data were abstracted from the articles and case reports and were combined in a cumulative synthesis. The frequency of identified diagnostic characteristics was calculated from the cumulative synthesis and evidence for pathophysiologic hypothesis as well as treatment options were evaluated using the GRADE criteria. The systematic search returned 2178 articles. After duplicates were removed, 1253 abstracts were reviewed and 183 were included. Fourteen diagnostic characteristics were identified, and the frequency of major characteristics was as follows: history of regular cannabis for any duration of time (100%), cyclic nausea and vomiting (100%), resolution of symptoms after stopping cannabis (96.8%), compulsive hot baths with symptom relief (92.3%), male predominance (72.9%), abdominal pain (85.1%), and at least weekly cannabis use (97.4%). The pathophysiology of CHS remains unclear with a dearth of research dedicated to investigating its underlying mechanism. Supportive care with intravenous fluids, dopamine antagonists, topical capsaicin cream, and avoidance of narcotic medications has shown some benefit in the acute setting. Cannabis cessation appears to be the best treatment. CHS is a cyclic vomiting syndrome, preceded by daily to weekly cannabis use, usually accompanied by symptom improvement with hot bathing, and resolution with cessation of cannabis. The pathophysiology underlying CHS is unclear. Cannabis cessation appears to be the best treatment.
Keywords: Cannabinoid hyperemesis syndrome; Cannabis; Cyclic vomiting syndrome; Marijuana.
Conflict of interest statement
Dr. Sorensen has no conflicts of interest to declare. Kristen DeSanto has no conflicts of interest to declare. Dr. Borgelt receives support from the Colorado Department of Public Health and Environment and the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Phillips receives support from NIH on Drug Abuse R15 DA041656 and R01 DA034957, and Dr. Monte receives support from NIH 1 K23 GM110516 and NIH CTSI UL1 TR001082.
Figures
Comment in
-
In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.J Med Toxicol. 2017 Jun;13(2):197. doi: 10.1007/s13181-017-0608-6. Epub 2017 Mar 9. J Med Toxicol. 2017. PMID: 28281175 Free PMC article. No abstract available.
-
In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.J Med Toxicol. 2017 Jun;13(2):198. doi: 10.1007/s13181-017-0610-z. Epub 2017 Mar 10. J Med Toxicol. 2017. PMID: 28283940 Free PMC article. No abstract available.
-
The Importance of Recognizing Cannabinoid Hyperemesis Syndrome from Synthetic Marijuana Use.J Med Toxicol. 2017 Jun;13(2):199-200. doi: 10.1007/s13181-017-0612-x. Epub 2017 Mar 28. J Med Toxicol. 2017. PMID: 28353201 Free PMC article. No abstract available.
-
In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use".J Med Toxicol. 2017 Jun;13(2):201. doi: 10.1007/s13181-017-0613-9. Epub 2017 Apr 5. J Med Toxicol. 2017. PMID: 28382464 Free PMC article. No abstract available.
Similar articles
-
Cannabinoid hyperemesis syndrome: A review.Rev Gastroenterol Mex (Engl Ed). 2025 Apr-Jun;90(2):214-226. doi: 10.1016/j.rgmxen.2025.02.002. Epub 2025 Jun 13. Rev Gastroenterol Mex (Engl Ed). 2025. PMID: 40517066 Review.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.Pharmacotherapy. 2017 Jun;37(6):725-734. doi: 10.1002/phar.1931. Epub 2017 May 12. Pharmacotherapy. 2017. PMID: 28370228
-
A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.CNS Drugs. 2018 Dec;32(12):1113-1129. doi: 10.1007/s40263-018-0577-6. CNS Drugs. 2018. PMID: 30361897
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Cited by
-
Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis.Front Pediatr. 2022 Feb 21;10:830280. doi: 10.3389/fped.2022.830280. eCollection 2022. Front Pediatr. 2022. PMID: 35265566 Free PMC article.
-
Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome.J Pediatr Pharmacol Ther. 2023;28(3):222-227. doi: 10.5863/1551-6776-28.3.222. Epub 2023 Jun 2. J Pediatr Pharmacol Ther. 2023. PMID: 37303765 Free PMC article.
-
The Development of Cannabinoids as Therapeutic Agents in the United States.Pharmacol Rev. 2024 Aug 15;76(5):915-955. doi: 10.1124/pharmrev.123.001121. Pharmacol Rev. 2024. PMID: 38849155 Review.
-
Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review.Life (Basel). 2025 Jun 27;15(7):1021. doi: 10.3390/life15071021. Life (Basel). 2025. PMID: 40724523 Free PMC article. Review.
-
Late-onset Very long-chain acyl-CoA dehydrogenase deficiency diagnosis complicated by fulminant myocarditis in adult patient.J Intensive Med. 2024 Jan 5;4(3):400-402. doi: 10.1016/j.jointm.2023.11.003. eCollection 2024 Jul. J Intensive Med. 2024. PMID: 39035620 Free PMC article. No abstract available.
References
-
- United Nations Office on Drugs and Crime. World Drug Report [Internet]. 2014 [cited 26 November 2016] Available at: http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
-
- Results from the 2014 National Survey on Drug Use and Health: summary of national findings [Internet]. 2014 [cited 27 November 2016] Available at: http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR....
-
- [No author listed] State marijuana laws in 2016. Governing the states and localities [Internet]. 2016 [cited 26 November 2016] Available at: http://www.governing.com/gov-data/state-marijuana-laws-map-medical-recre....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical